Immediate Impact

60 standout
Sub-graph 1 of 24

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
1 intermediate paper

Works of Philippe Jamme being referenced

Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations
2020

Author Peers

Author Last Decade Papers Cites
Philippe Jamme 149 109 103 22 248
Xuejing Aimee Wang 155 121 127 15 281
Shiaowen David Hsu 122 171 98 35 293
Morana Vojnic 159 128 124 23 264
Karin Berghoff 117 128 112 28 263
Dezuo Dong 74 112 112 20 267
Shi‐Xun Lu 86 110 96 21 247
Yichuan Yuan 58 53 77 19 241
Shenglan Huang 65 68 143 22 277
Benjamin Bonhomme 78 125 44 15 249
Phillipe Taniere 92 109 94 23 263

All Works

Loading papers...

Rankless by CCL
2026